Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease

Background and Purpose: Olfactory dysfunction (OD) is a common non-motor symptom of Parkinson disease (PD). However, the relationship between OD and neuropathologic proteins in cerebrospinal fluid (CSF) from PD patients remains unclear.Methods: 166 PD patients were included in the study. Overall olf...

Full description

Bibliographic Details
Main Authors: Peng Guo, Rui-dan Wang, Teng-hong Lian, Du-yu Ding, Ya-nan Zhang, Wei-Jiao Zhang, Dan-ning Li, Li-xia Li, Jing-hui Li, Hui-ying Guan, Shu-yang Yu, Li Liu, Yang Hu, Li-jun Zuo, Qiu-jin Yu, Xiao-min Wang, Wei Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2020.594324/full
id doaj-90d8329be4b6412b92092384c5f09383
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Peng Guo
Rui-dan Wang
Teng-hong Lian
Du-yu Ding
Ya-nan Zhang
Wei-Jiao Zhang
Dan-ning Li
Li-xia Li
Jing-hui Li
Hui-ying Guan
Shu-yang Yu
Li Liu
Yang Hu
Li-jun Zuo
Qiu-jin Yu
Xiao-min Wang
Wei Zhang
Wei Zhang
Wei Zhang
Wei Zhang
spellingShingle Peng Guo
Rui-dan Wang
Teng-hong Lian
Du-yu Ding
Ya-nan Zhang
Wei-Jiao Zhang
Dan-ning Li
Li-xia Li
Jing-hui Li
Hui-ying Guan
Shu-yang Yu
Li Liu
Yang Hu
Li-jun Zuo
Qiu-jin Yu
Xiao-min Wang
Wei Zhang
Wei Zhang
Wei Zhang
Wei Zhang
Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease
Frontiers in Aging Neuroscience
Parkinson disease
olfactory dysfunction
sniffin' sticks test
cerebrospinal fluid
neuropathologic proteins
author_facet Peng Guo
Rui-dan Wang
Teng-hong Lian
Du-yu Ding
Ya-nan Zhang
Wei-Jiao Zhang
Dan-ning Li
Li-xia Li
Jing-hui Li
Hui-ying Guan
Shu-yang Yu
Li Liu
Yang Hu
Li-jun Zuo
Qiu-jin Yu
Xiao-min Wang
Wei Zhang
Wei Zhang
Wei Zhang
Wei Zhang
author_sort Peng Guo
title Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease
title_short Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease
title_full Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease
title_fullStr Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease
title_full_unstemmed Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease
title_sort olfactory dysfunction and its association with neuropathologic proteins in cerebrospinal fluid from patients with parkinson disease
publisher Frontiers Media S.A.
series Frontiers in Aging Neuroscience
issn 1663-4365
publishDate 2020-12-01
description Background and Purpose: Olfactory dysfunction (OD) is a common non-motor symptom of Parkinson disease (PD). However, the relationship between OD and neuropathologic proteins in cerebrospinal fluid (CSF) from PD patients remains unclear.Methods: 166 PD patients were included in the study. Overall olfactory function was assessed by summing up the scores of olfactory threshold, discrimination, and identification by a Sniffin' Sticks test, based on which, patients were divided into PD with OD (PD-OD) and PD with no OD (PD-NOD) groups. CSF samples were obtained from 76 PD patients. The levels of neuropathologic proteins, including α-Synuclein, Aβ1-42, total tau (T-tau), and multiple forms of phosphorylated tau (P-tau) in CSF were measured by an enzyme-linked immunosorbent assay.Results: out of the 166 PD patients, 103 cases (62.0%) had OD. The scores of overall olfactory functions, and olfactory threshold, discrimination, and identification in the PD-OD group were all significantly lower than that in the PD-NOD group (P < 0.001). α-Synuclein level in CSF was significantly higher in the PD-OD group than the PD-NOD group (P < 0.05), and was significantly and negatively correlated with the scores of overall olfactory function, and olfactory discrimination and identification (P < 0.05). Aβ1-42 level in CSF was higher in the PD-OD group than the PD-NOD group, and was significantly and negatively correlated with the olfactory identification score (P < 0.05). T-tau level in CSF was significantly lower in the PD-OD group than the PD-NOD group (P < 0.05), and was significantly and positively correlated with the olfactory discrimination score (P < 0.05). There was no significant difference in P-tau level in CSF between the PD-OD and PD-NOD groups and no correlation between OD score and P-tau level in CSF.Conclusions: PD-OD includes the impairments of olfactory threshold, discrimination, and identification, and is associated with the significant elevation of α-Synuclein and the decrease of the T-tau level in CSF.
topic Parkinson disease
olfactory dysfunction
sniffin' sticks test
cerebrospinal fluid
neuropathologic proteins
url https://www.frontiersin.org/articles/10.3389/fnagi.2020.594324/full
work_keys_str_mv AT pengguo olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease
AT ruidanwang olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease
AT tenghonglian olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease
AT duyuding olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease
AT yananzhang olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease
AT weijiaozhang olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease
AT danningli olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease
AT lixiali olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease
AT jinghuili olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease
AT huiyingguan olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease
AT shuyangyu olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease
AT liliu olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease
AT yanghu olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease
AT lijunzuo olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease
AT qiujinyu olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease
AT xiaominwang olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease
AT weizhang olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease
AT weizhang olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease
AT weizhang olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease
AT weizhang olfactorydysfunctionanditsassociationwithneuropathologicproteinsincerebrospinalfluidfrompatientswithparkinsondisease
_version_ 1724386802760941568
spelling doaj-90d8329be4b6412b92092384c5f093832020-12-11T06:08:35ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652020-12-011210.3389/fnagi.2020.594324594324Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson DiseasePeng Guo0Rui-dan Wang1Teng-hong Lian2Du-yu Ding3Ya-nan Zhang4Wei-Jiao Zhang5Dan-ning Li6Li-xia Li7Jing-hui Li8Hui-ying Guan9Shu-yang Yu10Li Liu11Yang Hu12Li-jun Zuo13Qiu-jin Yu14Xiao-min Wang15Wei Zhang16Wei Zhang17Wei Zhang18Wei Zhang19Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Blood Transfusion, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of General Internal Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of General Internal Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Physiology, Capital Medical University, Beijing, ChinaDepartment of Neurology, Center for Cognitive Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaChina National Clinical Research Center for Neurological Disease, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaCenter of Parkinson's Disease, Beijing Institute for Brain Disorders, Beijing, ChinaBeijing Key Laboratory on Parkinson Disease, Beijing, ChinaBackground and Purpose: Olfactory dysfunction (OD) is a common non-motor symptom of Parkinson disease (PD). However, the relationship between OD and neuropathologic proteins in cerebrospinal fluid (CSF) from PD patients remains unclear.Methods: 166 PD patients were included in the study. Overall olfactory function was assessed by summing up the scores of olfactory threshold, discrimination, and identification by a Sniffin' Sticks test, based on which, patients were divided into PD with OD (PD-OD) and PD with no OD (PD-NOD) groups. CSF samples were obtained from 76 PD patients. The levels of neuropathologic proteins, including α-Synuclein, Aβ1-42, total tau (T-tau), and multiple forms of phosphorylated tau (P-tau) in CSF were measured by an enzyme-linked immunosorbent assay.Results: out of the 166 PD patients, 103 cases (62.0%) had OD. The scores of overall olfactory functions, and olfactory threshold, discrimination, and identification in the PD-OD group were all significantly lower than that in the PD-NOD group (P < 0.001). α-Synuclein level in CSF was significantly higher in the PD-OD group than the PD-NOD group (P < 0.05), and was significantly and negatively correlated with the scores of overall olfactory function, and olfactory discrimination and identification (P < 0.05). Aβ1-42 level in CSF was higher in the PD-OD group than the PD-NOD group, and was significantly and negatively correlated with the olfactory identification score (P < 0.05). T-tau level in CSF was significantly lower in the PD-OD group than the PD-NOD group (P < 0.05), and was significantly and positively correlated with the olfactory discrimination score (P < 0.05). There was no significant difference in P-tau level in CSF between the PD-OD and PD-NOD groups and no correlation between OD score and P-tau level in CSF.Conclusions: PD-OD includes the impairments of olfactory threshold, discrimination, and identification, and is associated with the significant elevation of α-Synuclein and the decrease of the T-tau level in CSF.https://www.frontiersin.org/articles/10.3389/fnagi.2020.594324/fullParkinson diseaseolfactory dysfunctionsniffin' sticks testcerebrospinal fluidneuropathologic proteins